Official website, the National Medical Insurance Bureau, recently published a reply to the recommendation No.9354 of the Third Session of the 13th National People's Congress. In response to the NPC representative's suggestion that pneumonia vaccine vaccination should be included in the full reimbursement of medical insurance, the National Medical Insurance Bureau replied that the relevant national regulations are clear, and preventive vaccines are not included in the scope of medical insurance payment. In addition, the number of people vaccinated is large and the total cost is high, which obviously exceeds the affordability of the medical insurance fund.

According to the "People's Republic of China (PRC) Vaccine Management Law" implemented on June 65, 438+09+February 65, 438+0, vaccines in China can be divided into planned immunization vaccines and unplanned immunization vaccines. Among them, the immunization program vaccine shall be subject to centralized bidding or unified negotiation by the competent health department of the State Council and the financial department of the State Council, and unified procurement shall be implemented by all provinces, autonomous regions and municipalities directly under the Central Government, and the government shall provide it to residents free of charge. At the same time, Article 30 of the Social Insurance Law of People's Republic of China (PRC) stipulates that the medical expenses that should be borne by public health are not included in the payment scope of the basic medical insurance fund. In addition, the Interim Measures for the Administration of Medication in Basic Medical Insurance promulgated in July 2020 pointed out that preventive vaccines are not included in the scope of medical insurance payment. Therefore, diseases prevention and control projects such as vaccines and vaccination costs should be solved through public health service funds.

In addition, according to the National Medical Insurance Bureau, at present, the financing level of basic medical insurance in China, especially for urban and rural residents, is low, and the per capita financing of medical insurance for urban and rural residents in 20 19 is only about 800 yuan. However, the number of people vaccinated is large and the total cost is high, which obviously exceeds the affordability of the medical insurance fund. Judging from the overall development of the medical insurance system at this stage, the people's demand for disease treatment, and the financing level and anti-risk ability of the medical insurance fund, the current basic medical insurance system is still based on providing basic disease treatment protection for the people, focusing on meeting the people's basic medical needs, and is unable to expand the payment scope to non-therapeutic items such as vaccines.

According to the National Medical Insurance Bureau, the next step will be to do a good job in epidemic prevention services in accordance with the relevant requirements of the Opinions of the Central Committee of the State Council on Deepening the Reform of the Medical Security System, and to study the vaccine cost in COVID-19 together with relevant departments.